# Role of the Mespere Venus 1000 in Predicting Heart Failure Hospital Readmissions

> **NCT02003040** · — · UNKNOWN · sponsor: **Mespere Lifesciences Inc.** · enrollment: 50 (estimated)

## Conditions studied

- ADHF

## Interventions

- **DEVICE:** Mespere Venus 1000 CVP System

## Key facts

- **NCT ID:** NCT02003040
- **Lead sponsor:** Mespere Lifesciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2016-04
- **Final completion:** 2016-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02003040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02003040, "Role of the Mespere Venus 1000 in Predicting Heart Failure Hospital Readmissions". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT02003040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*